ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Working capital

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.2B
P/E ratio
101.6x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndWorking capital (Million JPY)YoY (%)
Mar 31, 202611,350-3.90%
Mar 31, 202511,811+2.70%
Mar 31, 202411,501+0.54%
Mar 31, 202311,439+4.98%
Mar 31, 202210,896-0.23%
Mar 31, 202110,921+8.96%
Mar 31, 202010,023-3.51%
Mar 31, 201910,388-4.14%
Mar 31, 201810,837-10.73%
Mar 31, 201712,139-23.20%
Mar 31, 201615,806+29.65%
Mar 31, 201512,191

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat